4.8 Review

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz et al.

Summary: The study suggests a positive selection for the SARS-CoV-2 spike protein variant D614G in the UK, but no evidence of differences in COVID-19 mortality or clinical severity in patients infected with this variant. 614G is associated with higher viral load and younger age of patients compared to 614D.
Article Infectious Diseases

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

Kathy Leung et al.

Summary: Two new lineages of SARS-CoV-2 with the N501Y mutation in the receptor-binding domain of the spike protein have spread rapidly in the United Kingdom. The 501Y lineage without amino acid deletion Delta 69/Delta 70 was estimated to be 10% more transmissible than the 501N lineage, while the 501Y lineage with amino acid deletion Delta 69/Delta 70 was estimated to be 75% more transmissible than the 501N lineage.

EUROSURVEILLANCE (2021)

Review Virology

Kidney involvement in COVID-19 and its treatments

Xiucui Han et al.

Summary: In addition to affecting the lungs, SARS-CoV-2 can also frequently damage the kidneys, mainly manifesting as kidney tubular injury and proteinuria. Diagnosis and treatment of kidney complications should be strengthened to reduce patient mortality.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Medicine, General & Internal

South Africa responds to new SARS-CoV-2 variant

Munyaradzi Makoni

LANCET (2021)

Article Infectious Diseases

Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021

Pnina Shitrit et al.

Summary: An outbreak of SARS-CoV-2 Delta variant in a hospital infected 42 patients, staff, and family members, with 39 being fully vaccinated. The attack rate was relatively high, raising concerns about waning immunity.

EUROSURVEILLANCE (2021)

Article Multidisciplinary Sciences

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

Bryan A. Johnson et al.

Summary: The genetic mutation in SARS-CoV-2 resulted in better fitness in some cells but lower replication capacity in human respiratory cell lines. Despite reducing disease symptoms, the Delta PRRA mutant provided protection against rechallenge with the wildtype SARS-CoV-2.

NATURE (2021)

Letter Medicine, General & Internal

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Wenjuan Zhang et al.

Summary: The research focused on sequencing and phylogenetic analyses of SARS-CoV-2 isolates from symptomatic patients at Cedar-Sinai Medical Center in November-December 2020, providing insights into a surge in cases and hospitalizations during that period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Virology

Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K

Simone Di Giacomo et al.

Summary: In this study, analysis of more than 1,000,000 SARS-CoV-2 genomic sequences deposited on the GISAID public repository up to April 27, 2021, revealed a novel T478K mutation located on the SARS-CoV-2 Spike protein. The mutation has predominantly emerged in Mexico and the United States since January 2021, but has also been detected in several European countries.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Biotechnology & Applied Microbiology

A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice

Ruklanthi de Alwis et al.

Summary: The LUNAR-COV19 vaccine has been successfully developed to induce strong antibody response and cell-mediated immune response in mice. The vaccine at different doses can completely protect mice from SARS-CoV-2 challenge.

MOLECULAR THERAPY (2021)

Article Multidisciplinary Sciences

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

Catherine J. Reynolds et al.

Summary: Vaccination with a single dose of BNT162b2 after prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants. In contrast, individuals without prior infection showed reduced immunity against variants after receiving a single vaccine dose.

SCIENCE (2021)

Article Multidisciplinary Sciences

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

Nuno R. Faria et al.

Summary: A new variant of concern, P.1, with 17 mutations including three spike protein mutations associated with increased binding to human ACE2 receptors, emerged in Manaus, Brazil between November 2020 and January 2021. Molecular analysis suggests P.1 may be 1.7- to 2.4-fold more transmissible and that previous infection may provide 54 to 79% protection against P.1 infection compared to other lineages. Enhanced global genomic surveillance of such variants is crucial for pandemic response.

SCIENCE (2021)

Review Immunology

Cellular Immune Response to COVID-19 and Potential Immune Modulators

Xi Zhou et al.

Summary: The severity of COVID-19 is mainly related to host factors, especially cellular immune responses in patients. Treatment recommendations are tailored based on the dynamics of immune responses, including administering appropriate medications at different stages.

FRONTIERS IN IMMUNOLOGY (2021)

Article Microbiology

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Thomas P. Peacock et al.

Summary: Efficient transmission of SARS-CoV-2 among infected ferrets is dependent on a functional furin cleavage site in the spike protein. The virus has a selective advantage in lung cells and primary human airway epithelial cells due to a polybasic insertion, but replication may be impaired in certain cell lines.

NATURE MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Chang Liu et al.

Summary: Recent study examined the neutralizing ability of monoclonal antibodies, convalescent and vaccine sera against the Indian variants B.1.617.1 and B.1.617.2, showing that the neutralization of these variants is reduced compared to the ancestral strains, without widespread antibody escape as seen in other variants like B.1.351.
Article Cardiac & Cardiovascular Systems

Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients

Rene Schramm et al.

Summary: Ninety percent of cardiothoracic transplant patients showed no detectable immune response three weeks after receiving two doses of the BNT162b2 vaccine, in sharp contrast to the robust immune response seen in the control group.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Article Infectious Diseases

Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel

Yaniv Lustig et al.

Summary: The study found that healthcare workers vaccinated with Comirnaty showed reduced neutralising titres against the Gamma, Beta, and Delta variants, but the remaining neutralisation capacity may still be protective.

EUROSURVEILLANCE (2021)

Article Virology

SARS-CoV-2 B.1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate?

Stefano Pascarella et al.

Summary: Lineage B.1.617+, also known as G/452R.V3 and denoted by WHO as delta and kappa, is a newly described SARS-CoV-2 variant first identified in India in October 2020. Three sublineages, B.1.617.1 (kappa), B.1.617.2 (delta), and B.1.617.3, have been identified, with their potential impact on the current pandemic under investigation. This variant with 13 amino acid changes, including E484Q, L452R, and P681R, is characterized by a significant alteration in the surface electrostatic potential of the spike protein receptor-binding domain, particularly noticeable in the delta sublineage. The enhanced electrostatic potential change may facilitate the interaction between the B.1.617+ RBD and the ACE2 receptor, potentially increasing virus transmission.

JOURNAL OF MEDICAL VIROLOGY (2021)

News Item Multidisciplinary Sciences

THE RUSH TO STUDY FAST-SPREADING CORONAVIRUS VARIANTS

David Adam

NATURE (2021)

News Item Multidisciplinary Sciences

DELTA CORONAVIRUS VARIANT: SCIENTISTS BRACE FOR IMPACT

Ewen Callaway

NATURE (2021)

Letter Biochemistry & Molecular Biology

SARS-CoV-2 variants of concern are emerging in India

Jasdeep Singh et al.

NATURE MEDICINE (2021)

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Virology

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q

Alexander Wilhelm et al.

Summary: The study found that SARS-CoV-2 variants harboring the L452R substitution had reduced susceptibility to convalescent and vaccine-elicited sera and mAbs. Compared to the Epsilon variant, both the Kappa and Delta variants showed a greater reduction in neutralization by convalescent sera. Additionally, the Delta variant was resistant to imdemivab but could potentially be overcome with combination therapy involving casirivimab.

VIRUSES-BASEL (2021)

Article Biochemistry & Molecular Biology

The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design

Danielle C. Groves et al.

Summary: The global spread of the SARS-CoV-2 pandemic has triggered extensive genetic sequencing efforts to characterize the geographical distribution and molecular evolution of the virus. The emergence of the D614G variant as the dominant form worldwide has led to discussions about its effects on virus characteristics, clinical outcomes of infection, and host immune response.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Article Multidisciplinary Sciences

Cell entry mechanisms of SARS-CoV-2

Jian Shang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Virology

Hepatic complications of COVID-19 and its treatment

Dandan Tian et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Medicine, Research & Experimental

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Maria Pachetti et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Review Gastroenterology & Hepatology

The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19

Qing Ye et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 pandemic in India

C. Venkata S. Ram et al.

EUROPEAN HEART JOURNAL (2020)

Article Biochemistry & Molecular Biology

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Qianqian Li et al.

Article Biochemistry & Molecular Biology

Mutations Strengthened SARS-CoV-2 Infectivity

Jiahui Chen et al.

JOURNAL OF MOLECULAR BIOLOGY (2020)

Review Cardiac & Cardiovascular Systems

Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment

Qing Ye et al.

ESC HEART FAILURE (2020)

Article Immunology

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

Steven Sanche et al.

EMERGING INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV

Tao Zhou et al.

JOURNAL OF EVIDENCE BASED MEDICINE (2020)

Review Biochemistry & Molecular Biology

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

Shuo Su et al.

TRENDS IN MICROBIOLOGY (2016)

Article Medicine, General & Internal

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Ali Moh Zaki et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Medicine, General & Internal

A cluster of cases of severe acute respiratory syndrome in Hong Kong

KW Tsang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Medicine, General & Internal

A major outbreak of severe acute respiratory syndrome in Hong Kong

N Lee et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)